Take part in heart research
There are several ways to take part in heart research and it can be very rewarding. It gives you a chance to help others, as well as getting specialist care yourself for the duration of the trial. Many of our patients are sorry when a trial comes to and end, and frequently sign up to do another one if they fit the criteria!
There are several ways you can take part in heart research. We currently have two research fellows working in our department, who have the opportunity to carry out their MD projects. Our current project is looking at how Covid-19 affects the heart. Patients who have been admitted to hospital with Covid-19 and have been referred for a heart ultrasound scan (echocardiogram) are asked if they would be happy to take part. The data from their scan and blood test results from their admission are analysed and they are asked to attend for a second scan 6 months after they have gone home.
Want to take part in heart research in Harrow?
Our projects and trials are listed below. If you would like to volunteer for a trial or find out more information, please click on the ‘Find out how to volunteer’ button and drop us an email or use the contact form on our Get in Touch page.
All research operates under a favourable opinion from an National Research Ethics Service (NRES) Ethical committee and the Health Research Authority (HRA) as well as has permission of the Research and Development Department in the NHS Trust.
All our staff undertake specialist training to ensure that the research is carried to the highest standard and the patient’s interest is always the main priority.
Many of our patients enjoy taking part in research and have taken part in several different projects over the years.
We are really excited to be able to offer our patients the chance of taking part in this trial. Dapagliflozin is a medicine that belong to a group called SGLT2 inhibitors. It was first used in patients who had diabetes, but further research has shown it may help patients who are at risk of developing heart failure after a heart attack.This trial is being carried out in the UK and Sweden. If you agree to take part you will receive either dapagliflozin or a dummy tablet as well as your usual medicines. Neither you or your doctor will know what you are taking. You will be followed up by the specialist study team for the duration of the study, which will be around 2-3 years.
This study, which is sponsored by Novartis Pharmaceuticals, is looking at a new treatment for people who have a raised level of a particle found in the blood called lipoprotein (a). Raised levels of this particle is thought to put someone at an increased risk of hardening of the arteries. Having an increased level of this is genetic, rather than anything to do with your lifestyle.
People who already have heart disease are being asked to take part in this study. They will be eligible if a blood test shows that they have increased amounts of Lp(a). the study will last about 4 years and during that time you will regular be seen by the cardiologist and specialised research practitioner as part of your care.
If you are interested, please get in touch.
Unfortunately, recruitment for this study is now closed, although patients who have agreed to take part in the trial continue to do so. We will continue to give support throughout the trial as to how to live a healthier life style and the follow up study visits will continue with Emma and Gabriel.
This trial is suitable for patients who have been admitted to hospital with a small heart attack, and aims to find out if people with this sort of heart attack would benefit from immediate treatment through intervention (PCI /STENT) or if our current treatment pathway of letting the patient recover for a few days before any intervention is considered. If you are admitted to hospital and find that this applies to you the research team will come and find you and explain the study in detail. While this study is currently on hold, we hope to start it again in the Autumn.
We have will shortly be starting recruitment for a new trial in which we will be using high frequency ultrasound to look at the heart. This study will just take 1 day and you will have several scans during the study day. We will look after you during the day and make sure you have plenty of time to rest between scans.